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Key Issues for Clinicians Concerning Antiviral Treatments for 2009 
H1N1
Situation:
Although use of influenza antiviral drugs in the United States has increased during the 2009-2010 flu 
season, not all people recommended for antiviral treatment are getting treated.Listed below are important 
facts to consider when deciding whether a patient needs to be treated with antiviral medication.
It is critical to remember that it is not too late to treat, even if  symptoms began more than 48 hours 
ago. Although antiviral treatment is most effective when begun within 48 hours of influenza illness onset, 
studies have shown that hospitalized patients still benefit when treatment with oseltamivir is started more 
than 48 hours after illness onset. Outpatients, particularly those with risk factors for severe illness 
who are not improving, might also benefit from treatment initiated more than 48 hours after illness 
onset.
Recommendations for Clinicians:
Many 2009 H1N1 patients can benefit from antiviral treatment, and all hospitalized patients with 
suspected or confirmed 2009 H1N1 should receive antiviral treatment with a neuraminidase 
inhibitor - either oseltamivir or zanamivir - as early as possible after illness onset. Moderately ill 
patients, especially those with risk factors for severe illness, and those who appear to be getting worse, 
can also benefit from treatment with neuraminidase inhibitors.A full listing of risk factors for severe 
influenza is available at: http://www.cdc.gov/h1n1flu/highrisk.htm.
Although antiviral medications are recommended for treatment of 2009 H1N1 in patients with risk factors 
for severe disease, some people without risk factors may also benefit from antivirals. To date, 40% 
of children and 20% of adults hospitalized with complications of 2009 H1N1 did not have risk factors. 
Clinical judgment is always an essential part of treatment decisions.
When treatment of persons with suspected 2009 H1N1 influenza is indicated, it should be started 
empirically.If a decision is made to test for influenza, treatment should not be delayed while 
waiting for laboratory confirmation. The earlier antiviral treatment is given, the more effective it is for 
the patient. Also, rapid influenza tests often can give false negative results. If you suspect flu and feel 
antiviral treatment is warranted, treat even if the results of a rapid test are negative. Obtaining more
accurate testing results can take more than one day, so treatment should not be delayed while waiting for 
these test results.For more information on influenza testing, please see: 
http://www.cdc.gov/h1n1flu/guidance/diagnostic_tests.htm.
Although commercially produced pediatric oseltamivir suspension is in short supply, there are ample 
supplies of children's oseltamivir capsules, which can be mixed with syrup at home.In addition, 
pharmacies can compound adult oseltamivir capsules into a suspension for treatment of ill 
infants and children. Additional information on compounding can be found at: 
http://www.cdc.gov/H1N1flu/pharmacist/.
For More Information
Updated Interim Recommendations for the Use of Antiviral Medications in the Treatment and Prevention 
of Influenza for the 2009-2010 Season: http://www.cdc.gov/H1N1flu/recommendations.htm
Questions& Answers:
Antiviral Drugs, 2009-2010 Flu Season: http://www.cdc.gov/h1n1flu/antiviral.htm
Influenza Diagnostic Testing: http://www.cdc.gov/h1n1flu/diagnostic_testing_clinicians_qa.htm
Updated Interim Recommendations for Obstetric Health Care Providers Related to Use of Antiviral 
Medications in the Treatment and Prevention of Influenza for the 2009-2010 Season: 
http://www.cdc.gov/H1N1flu/pregnancy/antiviral_messages.htm
Antiviral Drugs: Summary of Side Effects: http://www.cdc.gov/flu/protect/antiviral/sideeffects.htm
General information for the public on antiviral drugs is available in “ 2009 H1N1 and Seasonal Flu: What 
You Should Know AboutFlu Antiviral Drugs” at http://www.cdc.gov/H1N1flu/antivirals/geninfo.htm.
Downloadable brochures and informational flyers, including one on antiviral drugs, are available at 
http://www.cdc.gov/h1n1flu/flyers.htm.
For the FDA page on antiviral influenza drugs:
http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm100228.htm
For additional information, you can also call CDC's toll-free hotline, 800-CDC-INFO(800-232-4636) TTY:
(888) 232-6348, which is available 24 hours a day, every day.
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